Skip to content

Higher Ground

Offering light in a chaotic world, a special section from The Washington Times

Advertisement

In this Dec. 17, 2015 file photo, Martin Shkreli, the former hedge fund manager under fire for buying a pharmaceutical company and ratcheting up the price of a life-saving drug, is escorted by law enforcement agents in New York after being taken into custody following a securities probe. Shkreli resigned as the head of Turing Pharmaceuticals, one of the companies he runs, and another, KaloBios Pharmaceuticals, said Monday, Dec. 21, in a printed statement that it terminated Shkreli last week.. (AP Photo/Craig Ruttle, File)

In this Dec. 17, 2015 file photo, Martin Shkreli, the former hedge fund manager under fire for buying a pharmaceutical company and ratcheting up the price of a life-saving drug, is escorted by law enforcement agents in New York after being taken into custody following a securities probe. Shkreli resigned as the head of Turing Pharmaceuticals, one of the companies he runs, and another, KaloBios Pharmaceuticals, said Monday, Dec. 21, in a printed statement that it terminated Shkreli last week.. (AP Photo/Craig Ruttle, File)

Featured Photo Galleries